Sabitlenmiş Tweet

Sharing strong 1-year safety and efficacy results from the #VITA trial of #VisiPlate aqueous shunt for open angle #glaucoma: morningstar.com/news/pr-newswi…
English
Avisi
343 posts

@avisi_tech
Working on a nanotech defense against blindness from glaucoma. #VisiPlate 💫























